LINC00102: A Drug Target / Disease Biomarker (G100359394)

Target Name: LINC00102

NCBI ID: G100359394

LINC00102

Other Name(s): Long intergenic non-protein coding RNA 102 | NCRNA00102 | long intergenic non-protein coding RNA 102

LINC00102: A Drug Target / Disease Biomarker

LINC00102 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is found in various tissues and cells throughout the body and is involved in the regulation of cell growth, differentiation, and survival.

LINC00102 is a small non-coding RNA molecule that consists of approximately 200 amino acid residues. It is expressed in a variety of tissues and cells throughout the body, including the brain, heart, liver, and muscle. It is also highly expressed in the placenta, which plays a critical role in the development and maintenance of fetal tissues.

One of the key functions of LINC00102 is its role in cell growth and differentiation. It has been shown to play a role in the regulation of cell proliferation and the maintenance of stem cell properties. LINC00102 has also been shown to play a role in the regulation of cell survival and the onset of age-related diseases.

In addition to its role in cell biology, LINC00102 has also been identified as a potential drug target. Its expression has been shown to be downregulated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that targeting LINC00102 may be a promising strategy for the development of new treatments for these diseases.

Another potential use of LINC00102 is as a biomarker for disease diagnosis and monitoring. Its expression has been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that LINC00102 may be a useful biomarker for the diagnosis and monitoring of these diseases.

In conclusion, LINC00102 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its role in cell growth and differentiation, as well as its potential as a drug target and biomarker, makes it an interesting target for further research and development. Further studies are needed to fully understand the role of LINC00102 in disease biology and its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 102

The "LINC00102 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00102 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets